Search is Powered by Google
Lymphoma / Leukemia News

British Lymphology Society Chooses Belfast For Prestigious Annual Conference

Main Category: Lymphoma / Leukemia
Also Included In: Cancer / Oncology;  Blood / Hematology;  Conferences
Article Date: 01 Oct 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The British Lymphology Society (BLS), the only UK body representing the medical professionals who treat lymphoedema, has chosen Belfast as the venue for its high profile annual conference.

Nearly 200 nursing and physiotherapy delegates, plus 11 pharmaceutical companies will be gathering at the Wellington Park Hotel for three days; 5-7 October. Delegates and exhibitors will be exploring and discussing innovative and leading edge developments in the management and treatment of Lymphoedema under the theme: Lymphoedema - Alternative Pathways.

In medical terms oedema means swelling. Lymphoedema is swelling resulting from damage to the body's lymph glands. It is a cruel, disabling and disfiguring condition with many complications and side effects. It can occur naturally (the exact cause has not yet been established, even with the power of modern genetic and DNA research); or it can arise from damage to the lymphatic system caused by major surgery - treatment for breast cancer being the prime example. Extensive swelling of limbs can severely limit mobility and make access to treatment very difficult. Many sufferers find it impossible to lead a normal lifestyle. Lymphoedema is also characterised by skin sores and ulceration.

There are also problems with diagnosis - many GP's regard swelling and oedema as an obesity, dietary and exercise problem. In fact, as our mothers and grandmothers so perceptively observed, it's a glandular problem - a problem with the lymph glands.

British Lymphology Society




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Introduction to CML image Introduction to CML

Chronic myeloid leukemia is a form of cancer that typically occurs in adults over the age of 40. Here's what you need to know about this disease...

View more videos...